Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Big4BioPhilly
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Big4BioPhilly
-
Take a look back at the 2019 that's been with the help of the
#Big4Bio Year-in-Review for Philadelphia!#lifesciences#market https://big4bio.com/spotlights/spotlight-big4biophiladelphia-2019-year-in-review/ …pic.twitter.com/ocdot9aaF4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
WindMIL is thrilled to announce a cancer immunotherapy pre-clinical research collaboration with University of Pennsylvania
#beatcancer#oncology#immunotherapyhttps://www.globenewswire.com/news-release/2020/02/05/1980129/0/en/WindMIL-Therapeutics-Announces-Cancer-Immunotherapy-Pre-Clinical-Research-Collaboration-with-University-of-Pennsylvania.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
Tomorrow is our 2020 Vendor Expo from 11-1 pm! This is a great opportunity to come out and learn how to improve your company. You won't want to miss out! If attending use the hashtag
#expo2020PABC and tag us in your pictures and posts from the event on twitter!@BiotechnologyPaHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Following Cerecor's acquisition of Aevi Genomic Medicine, the CEO of Aevi, Michael F. Cola, will now lead the combined company.
$CERChttps://www.bizjournals.com/philadelphia/news/2020/02/04/done-deal-maryland-biopharm-firm-completes.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Coupling GSK’s adjuvant systems with the pioneering platform technology we are funding has the potential to make more vaccine available more rapidly – by decreasing the dose of vaccine antigen required to protect each individual."
$GSKhttps://www.bizjournals.com/philadelphia/news/2020/02/03/glaxosmithkline-joins-battle-against.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"We’re all about helping patients make better, faster decisions at hospital discharge."
@phillymag@BizPhillyhttps://www.phillymag.com/healthcare-news/2020/02/03/repisodic-hospital-discharge/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
Another life sciences IPO for Greater PHL! Gene therapy startup
@Passage_Bio plans to go public via a $125 million IPO, to continue developing six gene therapy candidates for central nervous system diseases, including dementia.#DiscoveryStartsHerePHL
http://bit.ly/3b3HvV4 Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@BizPhilly takes a tour of the 600,000 square-foot Spring House Innovation Park, which will be dedicated to business and research.@phillymag#commercialrealestatehttps://www.phillymag.com/healthcare-news/2020/02/03/biotech-tour-inside-the-newly-rehabbed-spring-house-innovation-park/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2019 was a brilliant year for Greater Philadelphia's
#lifesciences sector! Learn why in the Year-in-Review report from#Big4Bio: https://big4bio.com/spotlights/spotlight-big4biophiladelphia-2019-year-in-review/ …pic.twitter.com/gdyfuHeFVo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"We’ll also be very lenient on early payment terms to help them get going for two reasons: We want to encourage innovation, and because little companies become big companies, and we want to be there when they do."
#commercialrealestatehttps://xconomy.com/new-york/2020/02/03/discovery-labs-converts-ex-gsk-king-of-prussia-site-into-rd-colony/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
Opportunity Alert
: Our Partners @Pepper_Law, are co-hosting - Show Me The Money: Guidance For Life Sciences Founders and Principals
Tuesday, February 4th @ 5pm
: @LifeSciencesPA
:https://bit.ly/2uTqSea Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"What we are hypothesizing here is that there can be a third mechanism…that even in the presence of CD19 those leukemic cells are unable to die when they are triggered by CAR-T."
@Penn https://foundry.lbl.gov/2019/11/07/putting-the-heat-on-microbial-resistance-with-organic-polymers/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
We're seeking disruptive solutions to
#healthsecurity threats and together with@BARDA offering the right support at the right time to#DRIVeInnovation and protect Americans from health security threats. https://sciencecenter.org/discover/drive-accelerator-network …pic.twitter.com/58UafTbw3z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2019 has been a brilliant year for the Greater Philadelphia region! Learn why inside Big4Bio's Year-in-Review report for Philadelphia: https://big4bio.com/spotlights/spotlight-big4biophiladelphia-2019-year-in-review/ …pic.twitter.com/2B7vAzs4qV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
Proteins, fats, carbohydrates and the very building blocks of all living things – DNA – are all organic molecules. Check out how assistant professor John Milligan is using blue light to develop these molecules. https://fal.cn/36inJ
@ResearchAtJeff#LifeatJeffersonpic.twitter.com/5Pyw2JbTZF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lannett will announce financial results for its fiscal 2020 Q2 on February 5, 2020.
$LCIhttps://www.prnewswire.com/news-releases/lannett-to-report-fiscal-2020-second-quarter-financial-results-host-conference-call-on-wednesday-february-5-300995586.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Review the year that's been—grab a copy of the 2019 Year-in-Review report for the Greater Philadelphia region!
@PhillyBio@LifeSciencesPA https://big4bio.com/spotlights/spotlight-big4biophiladelphia-2019-year-in-review/ …pic.twitter.com/fvzBlrKksk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@templemedschool researchers found that an existing anticancer drug called SAHA helped animals with a condition known as heart failure with preserved ejection fraction. https://medicine.temple.edu/news/temple-led-research-team-finds-common-form-heart-failure-could-be-treated-already-approved …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Greater Philadelphia
#lifesciences community almost tripled its venture funding in 2019. Look through the just-released@Big4Bio Year-in-Review for Greater Philadelphia for key information on the news stories and deals from 2019! https://big4bio.com/spotlights/spotlight-big4biophiladelphia-2019-year-in-review/ …pic.twitter.com/q0Zxryx17Q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
"Next week, we will be meeting with some of our SPEARHEAD-1 investigators, as well as patient groups and other partners, during the
@myESMO#sarcoma & GIST symposium. Let us know if you would want to meet.#cancer#celltherapy"pic.twitter.com/3F6OvNGXRo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.